EUVIMEDEUVIMED entdecken
Crossref

Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II–III NSCLC

J. van Diessen, L. Niazi, S.V. Hassan, J. Belderbos, R. Damhuis, W.V. Theelen

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S221

DOI: 10.1016/j.ijrobp.2026.06.470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von J. van Diessen und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Diessen, J. V., Niazi, L., Hassan, S., Belderbos, J., Damhuis, R., & Theelen, W. (2026). Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II–III NSCLC. International Journal of Radiation Oncology*Biology*Physics, 126(1), S221. https://doi.org/10.1016/j.ijrobp.2026.06.470

Vancouver

Diessen JV, Niazi L, Hassan S, Belderbos J, Damhuis R, Theelen W. Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II–III NSCLC. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S221. doi:10.1016/j.ijrobp.2026.06.470

BibTeX
@article{Diessen2026,
  author = {Diessen, J. van and Niazi, L. and Hassan, S.V. and Belderbos, J. and Damhuis, R. and Theelen, W.V.},
  title = {Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II–III NSCLC},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {S221},
  doi = {10.1016/j.ijrobp.2026.06.470}
}
Kostenlos starten →